Characterization of aging cancer-associated fibroblasts draws implications in prognosis and immunotherapy response in low-grade gliomas
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Characterization of aging cancer-associated fibroblasts draws implications in prognosis and immunotherapy response in low-grade gliomas
Authors
Keywords
-
Journal
Frontiers in Genetics
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-08-24
DOI
10.3389/fgene.2022.897083
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diagnostic and prognostic value of serum Chitinase 3‐like protein 1 in hepatocellular carcinoma
- (2022) Shuwei Wang et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Mechanical Properties in the Glioma Microenvironment: Emerging Insights and Theranostic Opportunities
- (2022) Adip G. Bhargav et al. Frontiers in Oncology
- Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockade
- (2022) Yuki Miyai et al. Life Science Alliance
- Cancer-Associated Fibroblasts and T Cells: From Mechanisms to Outcomes
- (2021) Alfie T. Baker et al. JOURNAL OF IMMUNOLOGY
- Protein signatures of centenarians and their offspring suggest centenarians age slower than other humans
- (2021) Paola Sebastiani et al. AGING CELL
- Inflammation-driven senescence-associated secretory phenotype in cancer-associated fibroblasts enhances peritoneal dissemination
- (2021) Tadahito Yasuda et al. Cell Reports
- Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Gliomas
- (2021) Zheng Zhao et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- Clinical and therapeutic relevance of cancer-associated fibroblasts
- (2021) Yang Chen et al. Nature Reviews Clinical Oncology
- GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA
- (2021) Chenwei Li et al. NUCLEIC ACIDS RESEARCH
- Identification of the Prognostic Signatures of Glioma With Different PTEN Status
- (2021) Pei Zhang et al. Frontiers in Oncology
- Cellular senescence in the tumor microenvironment and context‐specific cancer treatment strategies
- (2021) Tadahito Yasuda et al. FEBS Journal
- A Novel Cancer Stemness-Related Signature for Predicting Prognosis in Patients with Colon Adenocarcinoma
- (2021) Wei Wang et al. Stem Cells International
- Senescence and Immunoregulation in the Tumor Microenvironment
- (2021) Megan K. Ruhland et al. Frontiers in Cell and Developmental Biology
- Roles of the Mesenchymal Stromal/Stem Cell Marker Meflin/Islr in Cancer Fibrosis
- (2021) Masahide Takahashi et al. Frontiers in Cell and Developmental Biology
- Cancer‐associated fibroblasts that restrain cancer progression (rCAFs): hypotheses and perspectives
- (2020) Yuki Miyai et al. CANCER SCIENCE
- Fibrosis and cancer: A strained relationship
- (2020) Bram Piersma et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- FAM110B Inhibits Non-Small Cell Lung Cancer Cell Proliferation and Invasion Through Inactivating Wnt/β-Catenin Signaling
- (2020) Menghua Xie et al. OncoTargets and Therapy
- Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer
- (2020) Yann Kieffer et al. Cancer Discovery
- Macrophage M1/M2 polarization
- (2020) Chen Yunna et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The tumor microenvironment
- (2020) Nicole M. Anderson et al. CURRENT BIOLOGY
- Concepts of extracellular matrix remodelling in tumour progression and metastasis
- (2020) Juliane Winkler et al. Nature Communications
- Molecular Genetics and Functional Analysis Implicate CDKN2BAS1-CDKN2B Involvement in POAG Pathogenesis
- (2020) Sonika Rathi et al. Cells
- Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance
- (2020) Nuray Erin et al. DRUG RESISTANCE UPDATES
- Cancer-associated fibroblasts in gastrointestinal cancer
- (2019) Hiroki Kobayashi et al. Nature Reviews Gastroenterology & Hepatology
- The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment
- (2019) Lea Monteran et al. Frontiers in Immunology
- CD10 + GPR77 + Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness
- (2018) Shicheng Su et al. CELL
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
- (2018) Peng Jiang et al. NATURE MEDICINE
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015
- (2018) Quinn T Ostrom et al. NEURO-ONCOLOGY
- Role of Extracellular Matrix in Development and Cancer Progression
- (2018) Cameron Walker et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Classification of triple-negative breast cancers based on Immunogenomic profiling
- (2018) Yin He et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Putamen involvement and survival outcomes in patients with insular low-grade gliomas
- (2017) Yongheng Wang et al. JOURNAL OF NEUROSURGERY
- Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
- (2017) Arjun V Balar et al. LANCET
- The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision
- (2017) Takashi KOMORI NEUROLOGIA MEDICO-CHIRURGICA
- Comprehensive RNA-seq transcriptomic profiling in the malignant progression of gliomas
- (2017) Zheng Zhao et al. Scientific Data
- Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
- (2016) Willy Hugo et al. CELL
- Current management of low-grade gliomas
- (2016) Andreas F. Hottinger et al. CURRENT OPINION IN NEUROLOGY
- Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
- (2016) Jonathan M. Pitt et al. IMMUNITY
- Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis
- (2016) Megan K. Ruhland et al. Nature Communications
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
- (2015) Michael S. Rooney et al. CELL
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- RNA-seq of 272 gliomas revealed a novel, recurrentPTPRZ1-METfusion transcript in secondary glioblastomas
- (2014) Zhao-Shi Bao et al. GENOME RESEARCH
- Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation ofIDH
- (2014) J. Gregory Cairncross et al. JOURNAL OF CLINICAL ONCOLOGY
- Localizing seizure-susceptible brain regions associated with low-grade gliomas using voxel-based lesion-symptom mapping
- (2014) Yinyan Wang et al. NEURO-ONCOLOGY
- IDHMutation in Glioma
- (2014) Zorbey Turkalp et al. JAMA Neurology
- GSVA: gene set variation analysis for microarray and RNA-Seq data
- (2013) Sonja Hänzelmann et al. BMC BIOINFORMATICS
- Inferring tumour purity and stromal and immune cell admixture from expression data
- (2013) Kosuke Yoshihara et al. Nature Communications
- The sva package for removing batch effects and other unwanted variation in high-throughput experiments
- (2012) Jeffrey T. Leek et al. BIOINFORMATICS
- ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
- (2010) Matthew D. Wilkerson et al. BIOINFORMATICS
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More